Fukuvi Chemical IndustryFUKUVI CHEMICAL INDUSTRY CO.,LTD.7871東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP

Fukuvi Chemical Industry revenue and profit

Out of every ¥100 of sales, about ¥4 is left as operating profit. Revenue changed +1.6% from the prior year, operating profit +11.8%.

Five-year trend

Revenue¥40.6B
FY ending Mar 2022: ¥36.7B¥36.7BFY ending Mar 2023: ¥39.6B¥39.6BFY ending Mar 2024: ¥39.7B¥39.7BFY ending Mar 2025: ¥40B¥40BFY ending Mar 2026: ¥40.6B¥40.6BFY22FY23FY24FY25FY26
Operating income¥1.73B
FY ending Mar 2022: ¥1.27B¥1.27BFY ending Mar 2023: ¥1.55B¥1.55BFY ending Mar 2024: ¥1.75B¥1.75BFY ending Mar 2025: ¥1.55B¥1.55BFY ending Mar 2026: ¥1.73B¥1.73BFY22FY23FY24FY25FY26
Operating margin4.3%
FY ending Mar 2022: 3.5%3.5%FY ending Mar 2023: 3.9%3.9%FY ending Mar 2024: 4.4%4.4%FY ending Mar 2025: 3.9%3.9%FY ending Mar 2026: 4.3%4.3%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin4.1%
Asset turnover0.75×
ROA3.1%
ROA3.1%
Financial leverage1.58×
ROE4.9%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin4.1%
2022: 3.1%3.1%2023: 3.7%3.7%2024: 4.3%4.3%2025: 3.7%3.7%2026: 4.1%4.1%2223242526
Asset turnover0.75×
2022: 0.74×0.74×2023: 0.79×0.79×2024: 0.76×0.76×2025: 0.74×0.74×2026: 0.75×0.75×2223242526
ROA3.1%
2022: 2.3%2.3%2023: 3.0%3.0%2024: 3.3%3.3%2025: 2.7%2.7%2026: 3.1%3.1%2223242526
Financial leverage1.58×
2022: 1.60×1.60×2023: 1.60×1.60×2024: 1.63×1.63×2025: 1.62×1.62×2026: 1.58×1.58×2223242526
ROE4.9%
2022: 3.7%3.7%2023: 4.7%4.7%2024: 5.3%5.3%2025: 4.4%4.4%2026: 4.9%4.9%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20223.1%0.74×2.3%1.60×3.7%
20233.7%0.79×3.0%1.60×4.7%
20244.3%0.76×3.3%1.63×5.3%
20253.7%0.74×2.7%1.62×4.4%
20264.1%0.75×3.1%1.58×4.9%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue20.8%
2021: 25.4%25.4%2022: 23.9%23.9%2023: 21.5%21.5%2024: 21.0%21.0%2025: 20.7%20.7%2026: 20.8%20.8%212223242526
PPE ÷ total assets15.3%
2021: 19.0%19.0%2022: 17.8%17.8%2023: 16.8%16.8%2024: 15.5%15.5%2025: 15.5%15.5%2026: 15.3%15.3%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥1.03B
2021: ¥764M¥764M2022: ¥947M¥947M2023: ¥1.15B¥1.15B2024: ¥1.13B¥1.13B2025: ¥1.02B¥1.02B2026: ¥1.03B¥1.03B212223242526
R&D / revenue2.5%
2021: 2.1%2.1%2022: 2.6%2.6%2023: 2.9%2.9%2024: 2.9%2.9%2025: 2.5%2.5%2026: 2.5%2.5%212223242526
Receivable days—
2021: 116d116d212223242526
Payable days48d
2021: 149d149d2022: 153d153d2023: 146d146d2024: 136d136d2025: 73d73d2026: 48d48d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue36,74139,56739,73539,97340,594
Cost of revenue26,00727,95627,66727,98428,220
Gross profit10,73411,61212,06911,98912,374
SG&A9,46410,05710,31610,43910,642
Operating income1,2701,5541,7531,5501,733
Pretax income1,6432,1102,3982,0132,344
Income tax459569601482614
Net income attributable to owners1,1361,4821,7041,4661,680
Operating margin3.5%3.9%4.4%3.9%4.3%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 25%
Property, plant and equipment 15%
1%
Investment securities 14%
Other assets 45%

Funding

7%
Other liabilities 19%
Equity 74%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥12.3B¥12.1B¥11.2B¥14.2B¥13.5B
Total assets¥49.4B¥50.8B¥54.1B¥53.2B¥55B
Net assets¥33.3B¥34.3B¥37.2B¥37.5B¥40.6B
Share capital¥2.19B¥2.19B¥2.19B¥2.19B¥2.19B
Property, plant and equipment¥8.77B¥8.51B¥8.36B¥8.26B¥8.43B
Intangible assets excluding goodwill—¥432M¥800M¥794M¥750M
Investment securities¥3.49B¥4.24B¥6.79B¥5.84B¥7.67B
Current assets¥33.6B¥34.8B¥35.3B¥35.5B¥34B
Current liabilities¥14.5B¥14.8B¥14.2B¥13.4B¥11.1B
Trade payables¥10.9B¥11.2B¥10.3B¥5.57B¥3.72B
Short-term borrowings¥215M¥116M¥93M¥82M¥31M
Long-term borrowings¥66M¥33M—¥33M¥66M
Total liabilities¥16.1B¥16.5B¥16.9B¥15.7B¥14.4B
Non-controlling interests¥653M¥733M¥831M¥924M¥685M
Equity attributable to owners of parent¥30.9B¥31.6B¥32.8B¥33.6B¥34.8B
Retained earnings¥27.3B¥28.4B¥29.5B¥30.5B¥31.6B
Treasury stock-¥146M-¥467M-¥431M-¥598M-¥555M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第92期(2025/04/01-2026/03/31)

    ID S100YCP72026-06-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第91期(2024/04/01-2025/03/31)

    ID S100W56Y2025-06-25Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第90期(2023/04/01-2024/03/31)

    ID S100U17X2024-07-11Open
  • EDINET (FSA Japan)

    有価証券報告書-第89期(2022/04/01-2023/03/31)

    ID S100R13Q2023-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第88期(令和3年4月1日-令和4年3月31日)

    ID S100OEH42022-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第87期(令和2年4月1日-令和3年3月31日)

    ID S100LJML2021-06-17Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.